Hoping To Smooth Relations With FDA, Sarepta Moves On From CEO Garabedian

Seeing Garabedian’s relationship with FDA as strained, Sarepta promotes Chief Medical Officer to interim CEO post in hopes of keeping eteplirsen on track for a mid-year NDA filing.